跳至主要内容
临床试验/CTRI/2024/04/065911
CTRI/2024/04/065911尚未招募Phase 3 4

An Open Randomized Comparative clinical study of Amrutadi kwath (Sharangdhar samhita) with Kaishor guggul (Sharangdhar samhita) in the management of Vatarakta with special reference to Hyperuricemia.

未提供1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2024年5月7日最近更新:

试验速览

阶段
Phase 3 4
状态
尚未招募
入组人数
60
试验地点
1
主要终点
Sr. Uric acid

研究概览

简要总结

Ayurveda is traditional system of Indian medicine which is being used for management of various disease and has found to be effective in modern era as well. 

Vatarakta is a disease where both vata and rakta are affected by distinct etiological factors. Pathology of disease originates in blood vessel and then get settled in joints. Initially it affects greater toe and then small joints and peripheral joints where it causes burning sensation, severe pain, stiffness, swelling and pigmentation.

Out of many described medicine in texts, we choose Amrutadi kwath in comparison with kaishor guggul for the management of Vatarakta.

研究设计

研究类型
Interventional
分配方式
Randomized
盲法
None

入排标准

年龄范围
18.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • All genders will be included Age group 18 to 70 years All patients clinically diagnosed as vatarakta Hyperuricemic patients Patient having uric acid level 6.5 to 12 mg per dl.

排除标准

  • Patients with renal failure 2) Pregnant and lactating mother 3) patients with known case HIV and leprosy.

结局指标

主要结局

Sr. Uric acid

时间窗: 21 days

次要结局

  • Sandhishula(Sandhigraha)

研究者

发起方
未提供
责任方
Principal Investigator
主要研究者

Dr Ashwini Harish Agrawal

APMs, Ayurveda Mahavidyalay sion, Mumbai

研究点 (1)

Loading locations...

相似试验